Search
forResearch 10 of 1000+
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- LB1671 Large-scale skin scRNA-seq profiling highlights distinct body site-specific ligand-receptor interactions and pathways in keratinocytes
- Complex Changes in the Apoptotic and Cell Differentiation Programs during Initiation of the Hair Follicle Response to Chemotherapy
- Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation
- c-Kit - The Novel Receptor: Physiological Roles, Downstream Signaling and Implications in Cancer
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Platycladus orientalis Leaf Extract Promotes Hair Growth via Non-Receptor Tyrosine Kinase ACK1 Activation
- 1410 Non-coding double stranded RNA induces retinoic acid synthesis and retinoid signaling to control regeneration
- Targets to treat androgen excess in polycystic ovary syndrome
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
Community 10 of 118
- PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance
- GT20029 China Phase II Trial For AGA Reached Primary Endpoint
- Pyrilutamide phase III clinical trial results released
- Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
- Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases
- To everyone who cant use FIN and doesnt want to use RU
- Pyrilutamide just launched internationally, and all you're doing is hating
- The story of RU58841/ PSK3841
- Clascoterone study going on right now
- 0.5mg Dutasteride promotes more “regrowth” than 5mg oral Minoxidil